Phil Prime

• For Researchers

The incredible value of going public

We speak with two science communication masters about the benefits, ethics and sheer fun of communicating your research to the public. We speak with two science communication masters about the benefits, ethics and sheer fun of communicating your research to the public.

22 November 2021

• For Researchers

Professor Eithne Costello: On the road to early detection

Professor Eithne Costello on the challenges of ambitious trials, the evolution of early detection as a field in its own right and why a guiding framework is all important. Professor Eithne Costello on the challenges of ambitious trials, the evolution of early detection as a field in its own right and why a guiding framework is all important.

12 November 2021

• For Researchers

The director’s cut: How Dr Catherine Elliott sees the future of cancer research

We caught up with Director of Research, Dr Catherine Elliott, to talk pandemic recovery, research careers and the role of curiosity in a goal driven scientific environment We caught up with Director of Research, Dr Catherine Elliott, to talk pandemic recovery, research careers and the role of curiosity in a goal driven scientific environment

2 November 2021

• For Researchers

The award-winning researcher behind next generation sequencing

We speak to Professor Shankar Balasubramanian about his work on NGS, his incredible translational journey and the power of the pub… We speak to Professor Shankar Balasubramanian about his work on NGS, his incredible translational journey and the power of the pub…

15 October 2021

• For Researchers

Prize winning early detection research

Professor Rebecca Fitzgerald on the power of collaboration, taking risks and the rise of early detection as a hot topic for researchers... Professor Rebecca Fitzgerald on the power of collaboration, taking risks and the rise of early detection as a hot topic for researchers...

7 October 2021

• For Researchers
• Science & Technology

Delivering the future of paediatric brain tumour therapy

Dr Lisa Ruff tells us why drug delivery is so important for the treatment of paediatric brain tumours – and why hydrogels could be key to a breakthrough… Dr Lisa Ruff tells us why drug delivery is so important for the treatment of paediatric brain tumours – and why hydrogels could be key to a breakthrough…

7 October 2021

• For Researchers

A celebration of peer review

As part of Peer Review Week, we are very proud to celebrate the essential role our research community play in this process. Here we chat to Professor Marcus Munafò – a member of one of our funding committees As part of Peer Review Week, we are very proud to celebrate the essential role our research community play in this process. Here we chat to Professor Marcus Munafò – a member of one of our funding committees

21 September 2021

• Science & Technology
• For Researchers

Embedding research integrity at the core of our science

Cancer Research UK has deepened its commitment to good research practice by becoming a signatory of the Concordat to support research integrity Cancer Research UK has deepened its commitment to good research practice by becoming a signatory of the Concordat to support research integrity

28 July 2021

• For Researchers

Digging for early detection success in our sandpit workshops

Our sandpit workshops bring together researchers from different disciplines to develop research ideas for the early detection of cancer. Our sandpit workshops bring together researchers from different disciplines to develop research ideas for the early detection of cancer.

13 April 2021

• For Researchers

The journey to patient avatars: building a living biobank for ovarian cancer

In the search for new treatments for high-grade serous ovarian carcinoma, one Cancer Research-UK funded team built a living biobank. In the search for new treatments for high-grade serous ovarian carcinoma, one Cancer Research-UK funded team built a living biobank.

26 March 2021

• For Researchers

New research explores aneuploidy in children’s and young people’s cancers

We’re supporting new research exploring aneuploidy as a driver of children’s and young people’s cancer and a target for novel therapies. We’re supporting new research exploring aneuploidy as a driver of children’s and young people’s cancer and a target for novel therapies.

18 March 2021